EUVIMEDEUVIMED entdecken
Crossref

Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China

Li Lin, Junhao Huang, Junyue Fang iD, Jiahao Li, Wenying Cai, Jing Zhang iD, Sha Lu iD

Mycoses · 2023

DOI: 10.1111/myc.13599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mycoses, 2023. Verfasst von Li Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangz…. Hauptthemen laut MEDLINE: Sporothrix, Sporotrichosis. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Liyan Xi and Jing Zhang.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Sporotrichosis is a subcutaneous and chronic infection caused by traumatic inoculation of pathogenic sporothrix species, usually infecting the skins and subcutaneous tissues of humans and animals. However, the lack of epidemiological data required further molecular identification to describe the distribution of this fungus in our region. In this study, forty‐eight clinical sporothrix isolated from Sun Yat‐Sen Memorial Hospital were classified, and the susceptibility of each strain to seven antifungal agents was determined.

Methods

Forty strains of S. globosa and eight strains of S. shenkshii were identified via colony morphology and PCR sequencing of calmodulin gene.

Results

Antifungal susceptibility tests of the mycelial phase in vitro showed terbinafine (TRB) and luliconazole (LULI) were the most effective, followed by itraconazole (ITZ) and amphotericin B (AMB). By contrast, voriconazole (VCZ), 5‐flucytosine (5FC) and fluconazole (FCZ) have low efficacy with high MIC.

Conclusion

Our results showed a predominantly S. globosa infection trend in southern China. Simultaneously, sporothrix is sensitive to TRB, LULI, ITZ and AMB whereas resistant to FCZ. This study firstly reports antifungal sensitivity test in vitro and epidemiological correlation analysis of sporothrix in southern China, and also the first time to find that sporothrix is sensitive to LULI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SporothrixSporotrichosisAnimalsHumansAntifungal AgentsPrevalenceMicrobial Sensitivity TestsItraconazoleAmphotericin BTerbinafineFlucytosineChina

Stichwörter der Autor:innen

Sporothrixantifungal susceptibilitymolecular identificationmycelial phase

Substanzen

Antifungal AgentsItraconazoleAmphotericin BTerbinafineFlucytosine

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Department of Dermatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Cellular and Molecular Diagnostics Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

ORCID-Profile: Junyue Fang, Jing Zhang, Sha Lu

Förderung

  • Liyan Xi and Jing Zhang

Zitieren

APA

Lin, L., Huang, J., Fang, J., Li, J., Cai, W., Zhang, J., & Lu, S. (2023). Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China. Mycoses. https://doi.org/10.1111/myc.13599

Vancouver

Lin L, Huang J, Fang J, Li J, Cai W, Zhang J, et al. Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China. Mycoses. 2023. doi:10.1111/myc.13599

BibTeX
@article{Lin2023,
  author = {Lin, Li and Huang, Junhao and Fang, Junyue and Li, Jiahao and Cai, Wenying and Zhang, Jing and Lu, Sha},
  title = {Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China},
  journal = {Mycoses},
  year = {2023},
  doi = {10.1111/myc.13599}
}
Kostenlos starten →